Nivolumab
IRB00081673
Phase 1 small_molecule completed
Quick answer
Nivolumab for Brain and Nervous System is a Phase 1 program (small_molecule) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atrium Therapeutics
- Indication
- Brain and Nervous System
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed